Kepa Amillano
-
- Breast Cancer Treatment Studies 12
-
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 7
- PARP inhibition in cancer therapy 2
-
- Advanced Breast Cancer Therapies 9
-
- Breast Lesions and Carcinomas 3
-
- Estrogen and related hormone effects 4
-
- Cancer and Skin Lesions 2
- Co-authors
- Josep GumàL. MasanaAlba BosquetPaula Saavedra-GarcíaJosefa GironaEric W.‐F. LamSandra Guaita‐EsteruelasJoan Borràs
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Research (6 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Kepa Amillano
17 papers receiving 216 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 116
- Oncology 103
- Pulmonary and Respiratory Medicine 71
- Molecular Biology 91
- Pathology and Forensic Medicine 21
Countries citing papers authored by Kepa Amillano
This map shows the geographic impact of Kepa Amillano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kepa Amillano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kepa Amillano more than expected).
Fields of papers citing papers by Kepa Amillano
This network shows the impact of papers produced by Kepa Amillano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kepa Amillano. The network helps show where Kepa Amillano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kepa Amillano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 34 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 18 | |
| 12 | 2018 | 0 | |
| 13 | 2018 | 8 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 7 | |
| 17 | 2016 | 97 | |
| 18 | 2016 | 1 | |
| 19 | 2016 | 8 | |
| 20 | 2012 | 7 |
About Kepa Amillano
Kepa Amillano is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 221 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (7 papers), Estrogen and related hormone effects (4 papers), Breast Lesions and Carcinomas (3 papers), Cancer and Skin Lesions (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (116 citations), Oncology (103 citations) and Pulmonary and Respiratory Medicine (71 citations). Kepa Amillano has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Josep Gumà, L. Masana, Alba Bosquet, Paula Saavedra-García, Josefa Girona, Eric W.‐F. Lam, Sandra Guaita‐Esteruelas, Joan Borràs, Meritxell Bellet and Aleix Prat. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.